Emcure launched first generic version of Eisai Pharmaceutical’s Halaven (Eribulin) in India
Emcure Pharmaceuticals announced the launch of first generic version of Eisai Pharmaceutical’s Halaven (Eribulin) for the treatment of metastatic breast cancer (MBC).... Read More
DRL sells brand Sernivo; grants Promiseb and Trianex US marketing rights to Encore Dermatology
Posted on03 Apr 2019
Comments0
Dr. Reddy’s Laboratories Limited through its wholly owned subsidiary Promius Pharma, LLC, announces the sale of its rights for Sernivo (betamethasone dipropionate)... Read More
Check Your Competency in Data Integrity
Data Integrity refers to maintaining and assuring the accuracy and consistency of data over its entire product life-cycle. Over the last few years several, FDA... Read More
Merck to acquire immunotherapy company, Immune Design for US$ 300 million
Merck and Immune Design announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire... Read More
Insight on EU’s safety features of unique identifier & anti-tampering device on outer packaging require for medicines
As of 9 February 2019, most prescription medicines and some over-the-counter medicines for human use supplied in the European Union are required... Read More
Pfizer’s launches awareness and advocacy program on antibiotic resistance
Posted on28 Jan 2019
Comments0
ABOUT ICMR PFIZER CENTRE FOR AMR RESEARCH & EDUCATION In February 2018, the Indian Council of Medical Research (ICMR) and Pfizer signed... Read More
Pfizer and GlaxoSmithKline to merge consumer healthcare units
Pfizer Inc. and GlaxoSmithKline plc have entered into an agreement to create a premier global consumer healthcare company with robust iconic brands.... Read More
Boehringer Ingelheim’s ASF COMBAT market launch: East to use Tool in prevention of African swine fever
Boehringer Ingelheim has developed ASF COMBAT (ASF Comprehensive Online Management and Biosecurity Assessment Tool). This tool enables pig producers to evaluate areas... Read More
2018 Pharma Deal: Sanofi’s agreement to buy Bioverati @ $10.9 billion
Posted on18 Dec 2018
TagsBioverati, global pharma deals, global pharma licensing deal, pharma acquisition, pharma deal, Sanofi
Comments0
Sanofi and Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders, have entered into a definitive... Read More